 | • レポートコード：MRC2012A4849 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、不活化ポリオウイルスワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。不活化ポリオウイルスワクチンの種類別市場規模（ヒト二倍体細胞、サル腎臓細胞）、用途別市場規模（公共用、個人用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、IMBCA、GSK、Serum Institute (Bilthoven Biologicals)、 ・地域別グローバル市場分析 2015年-2020年 ・不活化ポリオウイルスワクチンの北米市場（アメリカ、カナダ、メキシコ） ・不活化ポリオウイルスワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・不活化ポリオウイルスワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・不活化ポリオウイルスワクチンの南米市場（ブラジル、アルゼンチン） ・不活化ポリオウイルスワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヒト二倍体細胞、サル腎臓細胞 ・用途別分析：公共用、個人用 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Inactivated Poliovirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Inactivated Poliovirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Inactivated Poliovirus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Inactivated Poliovirus Vaccine market has been segmented into
Human Diploid Cell
Monkey Kidney Cell
By Application, Inactivated Poliovirus Vaccine has been segmented into:
Public
Private
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Inactivated Poliovirus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Inactivated Poliovirus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Inactivated Poliovirus Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Inactivated Poliovirus Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Inactivated Poliovirus Vaccine Market Share Analysis
Inactivated Poliovirus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Inactivated Poliovirus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Inactivated Poliovirus Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Inactivated Poliovirus Vaccine are:
Sanofi
IMBCA
GSK
Serum Institute (Bilthoven Biologicals)
Among other players domestic and global, Inactivated Poliovirus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inactivated Poliovirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inactivated Poliovirus Vaccine, with price, sales, revenue and global market share of Inactivated Poliovirus Vaccine in 2018 and 2019.
Chapter 3, the Inactivated Poliovirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inactivated Poliovirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Inactivated Poliovirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Inactivated Poliovirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Inactivated Poliovirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inactivated Poliovirus Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Human Diploid Cell
1.2.3 Monkey Kidney Cell
1.3 Market Analysis by Application
1.3.1 Overview: Global Inactivated Poliovirus Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Public
1.3.3 Private
1.4 Overview of Global Inactivated Poliovirus Vaccine Market
1.4.1 Global Inactivated Poliovirus Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 IMBCA
2.2.1 IMBCA Details
2.2.2 IMBCA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 IMBCA SWOT Analysis
2.2.4 IMBCA Product and Services
2.2.5 IMBCA Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Serum Institute (Bilthoven Biologicals)
2.4.1 Serum Institute (Bilthoven Biologicals) Details
2.4.2 Serum Institute (Bilthoven Biologicals) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Serum Institute (Bilthoven Biologicals) SWOT Analysis
2.4.4 Serum Institute (Bilthoven Biologicals) Product and Services
2.4.5 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Inactivated Poliovirus Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Inactivated Poliovirus Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Inactivated Poliovirus Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Inactivated Poliovirus Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Inactivated Poliovirus Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Inactivated Poliovirus Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Inactivated Poliovirus Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Inactivated Poliovirus Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Inactivated Poliovirus Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Inactivated Poliovirus Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Inactivated Poliovirus Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Inactivated Poliovirus Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Inactivated Poliovirus Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
6.4 France Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Inactivated Poliovirus Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Inactivated Poliovirus Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Inactivated Poliovirus Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7.5 India Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Inactivated Poliovirus Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Inactivated Poliovirus Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Inactivated Poliovirus Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Inactivated Poliovirus Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Inactivated Poliovirus Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Inactivated Poliovirus Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Inactivated Poliovirus Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Inactivated Poliovirus Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Inactivated Poliovirus Vaccine Price by Type (2015-2020)
11 Global Inactivated Poliovirus Vaccine Market Segment by Application
11.1 Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Inactivated Poliovirus Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Inactivated Poliovirus Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Inactivated Poliovirus Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Inactivated Poliovirus Vaccine Market Forecast (2021-2025)
12.2.2 Europe Inactivated Poliovirus Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Inactivated Poliovirus Vaccine Market Forecast (2021-2025)
12.2.4 South America Inactivated Poliovirus Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Inactivated Poliovirus Vaccine Market Forecast (2021-2025)
12.3 Inactivated Poliovirus Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Inactivated Poliovirus Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Inactivated Poliovirus Vaccine Market Share Forecast by Type (2021-2025)
12.4 Inactivated Poliovirus Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Inactivated Poliovirus Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Inactivated Poliovirus Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Inactivated Poliovirus Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Inactivated Poliovirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Inactivated Poliovirus Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Inactivated Poliovirus Vaccine Major Business
Table 9. Sanofi Inactivated Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Inactivated Poliovirus Vaccine Product and Services
Table 12. Sanofi Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. IMBCA Basic Information, Manufacturing Base and Competitors
Table 14. IMBCA Inactivated Poliovirus Vaccine Major Business
Table 15. IMBCA Inactivated Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. IMBCA SWOT Analysis
Table 17. IMBCA Inactivated Poliovirus Vaccine Product and Services
Table 18. IMBCA Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GSK Basic Information, Manufacturing Base and Competitors
Table 20. GSK Inactivated Poliovirus Vaccine Major Business
Table 21. GSK Inactivated Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. GSK SWOT Analysis
Table 23. GSK Inactivated Poliovirus Vaccine Product and Services
Table 24. GSK Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Serum Institute (Bilthoven Biologicals) Basic Information, Manufacturing Base and Competitors
Table 26. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Major Business
Table 27. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Serum Institute (Bilthoven Biologicals) SWOT Analysis
Table 29. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product and Services
Table 30. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Inactivated Poliovirus Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 32. Global Inactivated Poliovirus Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Inactivated Poliovirus Vaccine Sales by Regions (2015-2020) (K Units)
Table 34. Global Inactivated Poliovirus Vaccine Sales Market Share by Regions (2015-2020)
Table 35. Global Inactivated Poliovirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Inactivated Poliovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 37. North America Inactivated Poliovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 38. North America Inactivated Poliovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Inactivated Poliovirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 40. Europe Inactivated Poliovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 41. Europe Inactivated Poliovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 42. Europe Inactivated Poliovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Inactivated Poliovirus Vaccine Sales by Regions (2015-2020) (K Units)
Table 44. Asia-Pacific Inactivated Poliovirus Vaccine Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Inactivated Poliovirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Inactivated Poliovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 47. South America Inactivated Poliovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 48. South America Inactivated Poliovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Inactivated Poliovirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Inactivated Poliovirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 51. Middle East & Africa Inactivated Poliovirus Vaccine Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Inactivated Poliovirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Inactivated Poliovirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 54. Global Inactivated Poliovirus Vaccine Sales by Type (2015-2020) (K Units)
Table 55. Global Inactivated Poliovirus Vaccine Sales Share by Type (2015-2020)
Table 56. Global Inactivated Poliovirus Vaccine Revenue by Type (2015-2020) (USD Million)
Table 57. Global Inactivated Poliovirus Vaccine Revenue Share by Type (2015-2020)
Table 58. Global Inactivated Poliovirus Vaccine Sales by Application (2015-2020) (K Units)
Table 59. Global Inactivated Poliovirus Vaccine Sales Share by Application (2015-2020)
Table 60. Global Inactivated Poliovirus Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 61. Global Inactivated Poliovirus Vaccine Market Share Forecast by Regions (2021-2025)
Table 62. Global Inactivated Poliovirus Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 63. Global Inactivated Poliovirus Vaccine Market Share Forecast by Type (2021-2025)
Table 64. Global Inactivated Poliovirus Vaccine Sales Forecast by Application (2021-2025)
Table 65. Global Inactivated Poliovirus Vaccine Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Inactivated Poliovirus Vaccine Picture
Figure 2. Global Sales Market Share of Inactivated Poliovirus Vaccine by Type in 2019
Figure 3. Human Diploid Cell Picture
Figure 4. Monkey Kidney Cell Picture
Figure 5. Inactivated Poliovirus Vaccine Sales Market Share by Application in 2018
Figure 6. Public Picture
Figure 7. Private Picture
Figure 8. Global Inactivated Poliovirus Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Inactivated Poliovirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Inactivated Poliovirus Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global Inactivated Poliovirus Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Inactivated Poliovirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Inactivated Poliovirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Inactivated Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Inactivated Poliovirus Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Inactivated Poliovirus Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America Inactivated Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Inactivated Poliovirus Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America Inactivated Poliovirus Vaccine Sales Market Share by Countries in 2018
Figure 45. North America Inactivated Poliovirus Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Inactivated Poliovirus Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Inactivated Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Inactivated Poliovirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Inactivated Poliovirus Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Inactivated Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Inactivated Poliovirus Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Inactivated Poliovirus Vaccine Revenue Market Share by Regions 2019
Figure 61. China Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Inactivated Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Inactivated Poliovirus Vaccine Sales Market Share by Countries in 2019
Figure 68. South America Inactivated Poliovirus Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Inactivated Poliovirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Inactivated Poliovirus Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Inactivated Poliovirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Inactivated Poliovirus Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Inactivated Poliovirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Inactivated Poliovirus Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Inactivated Poliovirus Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Inactivated Poliovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Inactivated Poliovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Inactivated Poliovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Inactivated Poliovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Inactivated Poliovirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
ポリオウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Poliovirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Poliovirus Vaccine market …- 糖衣錠キャンディー（サル肝細胞）ポリオミセテスワクチンの世界市場（～2026年） Poliomycetes vaccine in Dragee Candy (monkey liver cell), live employs live but attenuated causative virus of polio. It is used as a preventive vaccine in children against polio virus. Market Analysis and Insights: Global Poliomycetes Vaccine in Dragee Candy (Monkey Liver Cell) Market The global Pol…
- 日本脳炎ウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Japanese Encephalitis Virus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Japanese …
- ヒト用狂犬病ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Rabies Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Rabies Vaccine mar…
- 全細胞コレラワクチンの世界市場（～2026年） Whole Cell Cholera Vaccine is used to prevent Cholera. The factors that fuel the growth of the global whole cell cholera vaccine (recombinant B-subunit) market are rising incidence of cholera among people in endemic regions along with a lack of sanitation and hygiene in certain countries. Market Ana…